PSA - 2019 Universal Registration Document

CONSOLIDATED FINANCIAL STATEMENTS AT 31 DECEMBER 2019 Notes to the Consolidated Financial Statements at 31 December 2019

31 December 2019

31 December 2018

31 December 2017

At fair value through other compre-

At fair value through other compre-

At fair value through other compre-

At fair value through profit or loss

At fair value through profit or loss

At fair value through profit or loss

hensive income

hensive income

hensive income

(in million euros)

Level 1 fair value inputs: quoted prices in active markets Level 2 fair value inputs: based on observable market data Non-current financial liabilities

(13) (15)

- -

(1)

- -

-

- -

Other non-current liabilities

(10)

(5)

Derivative financial instruments on operating - liabilities

(124)

- -

(59)

- -

(203)

- -

Current financial liabilities

(2)

(11)

(2)

Level 3 fair value inputs: not based on observable market data TOTAL FINANCIAL LIABILITIES MEASURED AT FAIR VALUE

(154)

-

(81)

-

(210)

-

Informationabout financialliabilities not measured at fair value G.

31 December 2019

Fair value level

Carrying amount

Fair value

Level 1

Level 2

Level 3

(in million euros)

Liabilities Non-current financial liabilities Current financial liabilities

8,902 2,518

9,270 2,518

6,210

3,060

- -

47

2,471

31 December 2018

Fair value level

Carrying amount

Fair value

Level 1

Level 2

Level 3

(in million euros)

Liabilities Non-current financial liabilities Current financial liabilities

5,256

5,096 2,146

3,853

1,243 1,672

- -

2,171

474

31 December 2017

Fair value level

Carrying amount

Fair value

Level 1

Level 2

Level 3

(in million euros)

Liabilities Non-current financial liabilities Current financial liabilities

4,778 2,529

4,906 2,503

3,881

1,025 1,878

- -

625

Effect of financialinstrumentson profit or loss H.

2019

Analysis by class of instrument

At fair value through other comprehensive income

Instruments at fair value through profit or loss

Income Statement Impact

Instruments at amortised cost

(in million euros)

Manufacturing and sales companies Total interest income

22

- -

- - - - -

22

Total interest expense

(247)

(247)

Remeasurement

(36)

(33)

(3)

Disposal gains and dividends

23

23

-

Net impairment

11

(30)

41

TOTAL - MANUFACTURING AND SALES COMPANIES

(227)

(40)

-

(187)

234

PSA - GROUPE PSA - 2019 UNIVERSAL REGISTRATION DOCUMENT